Mizollen (Mizolastine)

Mizolastine works by selectively binding to peripheral H1‑histamine receptors, preventing histamine from triggering the cascade that causes vasodilation, increased vascular permeability, and sensory nerve activation. This blockade reduces the classic signs of allergic inflammation without significant central nervous system effects.

The dosage of Mizollen is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Safety data for mizolastine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order Mizollen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mizollen (mizolastine) is a second‑generation H1 antagonist offering effective allergy relief with a lower incidence of sedation compared with many first‑generation antihistamines. Its selectivity for peripheral receptors may provide a favorable safety profile, though individual response can vary.

Mizollen tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Mizollen is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious adverse reactions, though rare, include anaphylaxis, severe cutaneous adverse reactions such as Stevens‑Johnson syndrome, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, difficulty breathing, or jaundice.

Mizollen should be avoided in individuals with known hypersensitivity to mizolastine or any excipients in the tablet. It is also contraindicated in patients with severe hepatic impairment and should be used with caution in those with renal dysfunction.